September 02, 2025

New Bruton’s Tyrosine Kinase Inhibitor Improves Platelet Response

The FDA has approved rilzabrutinib (Wayrilz) as the first Bruton’s tyrosine kinase inhibitor for adults with chronic or persistent immune thrombocytopenia who have had an insufficient response to prior therapy.

Conexiant

September 02, 2025

New Maintenance Option for Early Alzheimer’s Approved by FDA

FDA approves Leqembi IQLIK (lecanemab-irmb), a once-weekly subcutaneous autoinjector for maintenance treatment of early Alzheimer’s disease.

Conexiant

September 02, 2025

ADA seeks new dentists to help address workforce shortages through ambassador program

The American Dental Association is seeking new dentists to serve as workforce ambassadors.

ADA News

September 02, 2025

Body Image and Quality of Life in Advanced Breast Cancer: The State of the Science

Explore the intricate relationship between body image and quality of life in advanced breast cancer patients, revealing gaps in existing research and highlighting the need for enhanced psychosocial support.

JADPRO

September 02, 2025

Dental workforce transitioning to younger, female dentists

The face of dentistry is changing to a younger and more female workforce, according to a new report from the ADA Health Policy Institute.

ADA News

September 02, 2025

Robotic Surgery May Improve Emergency Colectomy Outcomes

Expanding robotic surgery in urgent settings.

Conexiant

September 02, 2025

Semaglutide, Tirzepatide Cut HFpEF Events

Real-world JAMA analysis finds semaglutide and tirzepatide outperform sitagliptin; no meaningful difference in a head-to-head comparison.

Conexiant

September 02, 2025

Bile Acid Biomarker Stratifies HBV Cirrhosis

Antiviral therapy lowers taurochenodeoxycholic acid concentrations in patients with hepatitis B virus cirrhosis, reflecting changes in bile acid balance with viral suppression.

Conexiant

September 02, 2025

OTC Contraception Pill Linked to More Birth Control Starts

Over-the-counter access to progestin-only oral contraceptives shows higher use among patients with prior pregnancies and those not receiving recent contraceptive counseling.

Conexiant